Shengni Hua

1.6k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

Shengni Hua is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shengni Hua has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Shengni Hua's work include RNA modifications and cancer (10 papers), MicroRNA in disease regulation (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Shengni Hua is often cited by papers focused on RNA modifications and cancer (10 papers), MicroRNA in disease regulation (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Shengni Hua collaborates with scholars based in China and United States. Shengni Hua's co-authors include Weiyi Fang, Dehua Wu, Li Liu, Chengdong Liu, Qiaofen Fu, Meixiao Zhan, Ligong Lu, Yue Fan, Yiyu Chen and Chuanhui Cao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Shengni Hua

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy

2024 55 citations Shengni Hua et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shengni Hua China	16	829	587	253	122	76	22	1.1k
Changzhi Huang China	21	1.0k 1.2×	697 1.2×	239 0.9×	119 1.0×	60 0.8×	56	1.3k
Songbing He China	20	736 0.9×	519 0.9×	194 0.8×	112 0.9×	61 0.8×	34	957
Min Kyung Ju South Korea	12	691 0.8×	469 0.8×	365 1.4×	136 1.1×	100 1.3×	16	1.1k
Ye Song China	18	776 0.9×	507 0.9×	186 0.7×	168 1.4×	83 1.1×	44	1.1k
Xiaoting Jia China	19	941 1.1×	585 1.0×	227 0.9×	87 0.7×	49 0.6×	31	1.2k
Shuang Han China	16	793 1.0×	589 1.0×	239 0.9×	85 0.7×	70 0.9×	21	1.1k
Xiaoling Wu China	21	758 0.9×	543 0.9×	170 0.7×	83 0.7×	79 1.0×	54	996
Hyun Min Jeon South Korea	13	657 0.8×	445 0.8×	355 1.4×	134 1.1×	107 1.4×	18	1.1k
Jianjun Li China	18	684 0.8×	671 1.1×	224 0.9×	113 0.9×	84 1.1×	30	1.1k
Yun-Xin Lu China	13	806 1.0×	725 1.2×	262 1.0×	165 1.4×	68 0.9×	14	1.2k

Countries citing papers authored by Shengni Hua

Since Specialization

Citations

This map shows the geographic impact of Shengni Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengni Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengni Hua more than expected).

Fields of papers citing papers by Shengni Hua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengni Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengni Hua. The network helps show where Shengni Hua may publish in the future.

Co-authorship network of co-authors of Shengni Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Shengni Hua. A scholar is included among the top collaborators of Shengni Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengni Hua. Shengni Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hua, Shengni, et al.. (2023). Pyroptosis and inflammasomes in cancer and inflammation. SHILAP Revista de lepidopterología. 4(5). e374–e374. 22 indexed citations

Li, Wei, Meixiao Zhan, Yingyao Quan, et al.. (2020). Modulating the tumor immune microenvironment with sunitinib malate supports the rationale for combined treatment with immunotherapy. International Immunopharmacology. 81. 106227–106227. 11 indexed citations

Ma, Feng, Meixiao Zhan, Xiangyu Yang, et al.. (2020). Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression. Cell Death and Disease. 11(4). 225–225. 31 indexed citations

Huang, Jianwen, et al.. (2020). Interactome analysis of gene expression profiles identifies CDC6 as a potential therapeutic target modified by miR-215-5p in hepatocellular carcinoma. International Journal of Medical Sciences. 17(18). 2926–2940. 9 indexed citations

Hua, Shengni, Yingyao Quan, Meixiao Zhan, et al.. (2020). Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis. Aging. 12(6). 5439–5468. 28 indexed citations

Quan, Yingyao, et al.. (2019). Resveratrol bidirectionally regulates insulin effects in skeletal muscle through alternation of intracellular redox homeostasis. Life Sciences. 242. 117188–117188. 13 indexed citations

Hua, Shengni, Yingyao Quan, Meixiao Zhan, et al.. (2019). miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1. Cancer Cell International. 19(1). 203–203. 72 indexed citations

Hua, Shengni, Chengdong Liu, Li Liu, & Dehua Wu. (2018). miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA. Biochemical and Biophysical Research Communications. 496(3). 947–954. 69 indexed citations

Hua, Shengni, Ling Lei, Ling Deng, et al.. (2018). miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 37(12). 1624–1636. 97 indexed citations

10.

Hu, Wei, Lushan Xiao, Chuanhui Cao, Shengni Hua, & Dehua Wu. (2016). UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Oncotarget. 7(12). 15161–15172. 58 indexed citations

11.

Fu, Qiaofen, Yan Liu, Yue Fan, et al.. (2015). Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. Journal of Hematology & Oncology. 8(1). 22–22. 211 indexed citations

12.

Hua, Shengni, Lushan Xiao, & Dehua Wu. (2015). [Effect of HMGB1 on proliferation of human nasopharyngeal carcinoma cell line C666-1 in vitro].. PubMed. 35(11). 1540–5. 3 indexed citations

13.

Zhao, Mengyang, Weiyi Fang, Yan Wang, et al.. (2015). Enolase-1 is a therapeutic target in endometrial carcinoma. Oncotarget. 6(17). 15610–15627. 50 indexed citations

14.

Liu, Zhen, Yan Chen, Shengni Hua, et al.. (2014). Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma. BMC Cancer. 14(1). 274–274. 20 indexed citations

15.

Jiang, Qingping, Shengni Hua, Mengyang Zhao, et al.. (2014). High Nuclear Expression of HDGF Correlates with Disease Progression and Poor Prognosis in Human Endometrial Carcinoma. Disease Markers. 2014. 1–7. 16 indexed citations

16.

Wu, Qinghua, Z Liu, Xiaojun Luo, et al.. (2014). Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death and Disease. 5(4). e1155–e1155. 150 indexed citations

17.

Liu, Zhen, Huiling Yang, Yan Zhen, et al.. (2014). Candidate tumour suppressor CCDC19 regulates miR‐184 direct targeting of C‐Myc thereby suppressing cell growth in non‐small cell lung cancers. Journal of Cellular and Molecular Medicine. 18(8). 1667–1679. 41 indexed citations

18.

Zhen, Yan, Yanfen Ye, Xiaoli Yu, et al.. (2013). Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma. PLoS ONE. 8(6). e64976–e64976. 31 indexed citations

19.

Zhen, Yan, Zhen Liu, Huiling Yang, et al.. (2013). Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell Death and Disease. 4(10). e872–e872. 111 indexed citations

20.

Jiang, Qingping, Huiling Yang, Shengni Hua, et al.. (2013). Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma. Histopathology. 64(5). 722–730. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact